I think you're right, Iceman. Something does have to give on this one and I think spinning off the Vax division would actually see results in the SP over the next 6 months. It would, at the least, show just how much in real terms the division has been costing the company and I'd wager blast us across truly CF+ in short order.
It's not about the SP right now though, it's about decisive action. Either prove the Vax division has legs in terms of a real HPV collab with $$, or divest it.
- Forums
- ASX - By Stock
- AVR
- Ann: Admedus Releases Results of HSV-2 Phase IIa Study
Ann: Admedus Releases Results of HSV-2 Phase IIa Study, page-184
-
- There are more pages in this discussion • 167 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$14.50 |
Change
-0.500(3.33%) |
Mkt cap ! $311.5M |
Open | High | Low | Value | Volume |
$15.00 | $15.00 | $14.50 | $28.99K | 1.97K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 62 | $14.50 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.74 | 401 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 71 | 14.500 |
1 | 60 | 14.350 |
1 | 200 | 14.300 |
1 | 38 | 14.260 |
1 | 200 | 14.200 |
Price($) | Vol. | No. |
---|---|---|
14.750 | 667 | 2 |
14.760 | 347 | 1 |
14.850 | 47 | 1 |
14.900 | 9 | 1 |
14.970 | 47 | 1 |
Last trade - 10.40am 15/08/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online